NASDAQ
Altimmune, Inc. (ALT) has a revenue compound annual growth rate of -65.33% over 5 years and -42.64% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.